Table 1.
Patient Characteristics | hrHPV+ (N = 65) | hrHPV- (N = 65) | P value |
---|---|---|---|
Age | |||
Mean (SD, range) | 36.6 (9.9, 25–69) | 34.3 (7.9, 23–64) | 0.139 |
Disease Status, n/N (%) | <0.0001 | ||
Normal* /HPV | 12/65 (18.5) | 43/65 (66.2) | |
CIN1 | 13/65 (20.0) | 17/65 (26.1) | |
CIN2 | 21/65 (32.3) | 2/65 (3.1) | |
CIN3 | 14/65 (21.5) | 3/65 (4.6) | |
Cancer | 5/65 (7.7) | 0/65 (0.0) | |
Ethnicity, n/N (%) | 0.077 | ||
Caucasian | 56/65 (86.2) | 51/65 (78.5) | |
Asian | 6/65 (9.2) | 3/65 (4.6) | |
Black | 3/65 (4.6) | 7/65 (10.8) | |
Mixed⁎⁎ | 0/65 (0.0) | 4/65 (6.1) | |
Parity, n/N (%) | 1.000 | ||
Nulliparous | 46/65 (70.8) | 48/65 (73.9) | |
Parous | 16/65 (24.6) | 17/65 (26.1) | |
Unknown | 3/65 (4.6) | 0/65 (0.0) | |
Smoking Status, n/N (%) | 0.302 | ||
Current smoker | 18/65 (27.7) | 13/65 (20.0) | |
Non/Ex-smoker | 44/65 (67.7) | 52/65 (80.0) | |
Unknown | 3/65 (4.6) | 0/65 (0.0) | |
Contraception, n/N (%) | 0.653 | ||
Nil | 24/65 (36.9) | 28/65 (43.1) | |
Condoms | 12/65 (18.5) | 11/65 (16.9) | |
COCP/POP | 16/65 (24.6) | 14/65 (21.5) | |
IUCD/IUD/Mirena/Contraceptive (injection/depot/implant/patch) | 6/65 (9.2) | 11/65 (16.9) | |
Unknown | 7/65 (10.8) | 1/65 (1.6) | |
Menopause, n/N (%) | 0.719 | ||
Pre-menopausal | 60/65 (92.3) | 57/65 (87.7) | |
Post-menopausal | 5/65 (7.7) | 3/65 (4.6) | |
Unknown | 0/65 (0.0) | 5/65 (7.7) |
Normal includes: diagnosis confirmed after histology (n = 32) and cytology (n = 17).
Mixed includes: Afro-Caribbean/Irish; White African; Afro-Caribbean/British.